Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P G Wiles

Showing results (51-60 of 58) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 58 results.
Diabetic Medicine : a Journal of the British Diabetic Association|July 1, 1993
The degree of day-to-day variation in food intake in diabetic patientsE J Close, P G Wiles, J A Lockton, et al.
Thrombosis and Haemostasis|June 3, 1987
Hormonal control of haemostasis during hypoglycaemia in diabetes mellitusP J Grant, M H Stickland, P G Wiles, et al.
Diabetologia|February 1, 1988
Regional variation in skin blood flow response to hypoglycaemia in type 1 (insulin-dependent) diabetic patients without complicationsP G Wiles, P J Grant, M H Stickland, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|December 1, 1988
Acute changes in blood glucose concentration do not promote thrombin generation or fibrin breakdown in type 1 diabetesP J Grant, M H Stickland, P G Wiles, et al.
Clinical Endocrinology|November 1, 1984
The role of endogenous opioids in the chlorpropamide alcohol flushC Johnston, P G Wiles, S Medbak, et al.
Diabetes Care|November 1, 1982
A double-blind crossover trial comparing human insulin (recombinant DNA) with animal insulins in the treatment of previously insulin-treated diabetic patientsA J Clark, P G Wiles, J M Leiper, et al.
Lancet (London, England)|August 14, 1982
Biosynthetic human insulin in the treatment of diabetes. A double-blind crossover trial in established diabetic patientsA J Clark, R O Adeniyi-Jones, G Knight, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|December 21, 2010
Protection Against Nephropathy in Diabetes with Atorvastatin (PANDA): a randomized double-blind placebo-controlled trial of high- vs. low-dose atorvastatin(1)M K Rutter, H R Prais, V Charlton-Menys, et al.
Pageof 6

Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
Diabetic Medicine : a Journal of the British Diabetic Association|July 1, 1993
The degree of day-to-day variation in food intake in diabetic patientsE J Close, P G Wiles, J A Lockton, et al.
Thrombosis and Haemostasis|June 3, 1987
Hormonal control of haemostasis during hypoglycaemia in diabetes mellitusP J Grant, M H Stickland, P G Wiles, et al.
Diabetologia|February 1, 1988
Regional variation in skin blood flow response to hypoglycaemia in type 1 (insulin-dependent) diabetic patients without complicationsP G Wiles, P J Grant, M H Stickland, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|December 1, 1988
Acute changes in blood glucose concentration do not promote thrombin generation or fibrin breakdown in type 1 diabetesP J Grant, M H Stickland, P G Wiles, et al.
Clinical Endocrinology|November 1, 1984
The role of endogenous opioids in the chlorpropamide alcohol flushC Johnston, P G Wiles, S Medbak, et al.
Diabetes Care|November 1, 1982
A double-blind crossover trial comparing human insulin (recombinant DNA) with animal insulins in the treatment of previously insulin-treated diabetic patientsA J Clark, P G Wiles, J M Leiper, et al.
Lancet (London, England)|August 14, 1982
Biosynthetic human insulin in the treatment of diabetes. A double-blind crossover trial in established diabetic patientsA J Clark, R O Adeniyi-Jones, G Knight, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|December 21, 2010
Protection Against Nephropathy in Diabetes with Atorvastatin (PANDA): a randomized double-blind placebo-controlled trial of high- vs. low-dose atorvastatin(1)M K Rutter, H R Prais, V Charlton-Menys, et al.
Pageof 6